Trade

Poly Medicure share price

Balanced risk
  • 44%Low risk
  • 44%Moderate risk
  • 44%Balanced risk
  • 44%High risk
  • 44%Extreme risk
  • 1,694.00(2.69%)
    May 12, 2026 15:29:58 PM IST
    • NSE
    • BSE
  • Vol : 200.73 K (NSE + BSE)
    Last 20 day avg : 138.39 K

Poly Medicure is trading 2.69% upper at Rs 1,694.00 as compared to its last closing price. Poly Medicure has been trading in the price range of 1,704.10 & 1,616.35. Poly Medicure has given -6.93% in this year & 8.05% in the last 5 days. There are 5 analysts who have initiated coverage on Poly Medicure. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 70.93 Crores in its last quarter.Listed peers of Poly Medicure include Laxmi Dental (-5.23%), One Global Service Provider (-4.26%), Hemant Surgical Industries (5.03%).The Mutual Fund holding in Poly Medicure was at 8.84% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Poly Medicure was at 5.92% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 13, 2026, 12:20 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.73
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.21
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.57
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
1,616.35
Highest
1,704.10
52 week range
Lowest
1,184.00
Highest
2,587.55
Poly Medicure Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Laxmi Dental
Bearish
203.65-5.231,124.0142.226.93-7.32
One Global Service Provider
Bearish
395.20-4.26772.3469.8717.75-0.47
Hemant Surgical Industries
Bullish
380.005.03495.4636.135.03-36.93
PREVEST DENPRO
Bearish
420.001.82504.1232.305.550.20-
Mallcom (India)
Bearish
1,026.90-3.81642.3219.462.460.260.84
Mutual Fund Ownership
View all
SBI Healthcare Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 114.42
  • % of AUM 3.10
Quant Small Cap Fund Growth
4/5
  • Amount Invested (Cr.) 722.49
  • % of AUM 2.56
Invesco India ESG Integration Stategy Fund Regular Growth
3/5
  • Amount Invested (Cr.) 8.76
  • % of AUM 1.81
Invesco India ELSS Tax Saver Fund Growth
3/5
  • Amount Invested (Cr.) 50.68
  • % of AUM 1.78
Motilal Oswal Nifty MidSmall Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.38
  • % of AUM 1.55
Poly Medicure Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-05Quarterly Results
2025-11-08Quarterly Results
2025-08-08Quarterly Results & Others
2025-05-06Audited Results & Final Dividend
2025-02-03Quarterly Results & Others
About the company Poly Medicure
  • IndustryMedical Equipment & Supplies
  • ISININE205C01021
  • BSE Code531768
  • NSE CodePOLYMED
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
  • Management Info
  • Naresh VijayvargiyaChief Financial Officer
  • Avinash ChandraCompliance Officer, Company Secretary
  • Himanshu BaidManaging Director, Executive Director
  • Rishi BaidJoint Managing Director, Executive Director
  • Vishal BaidExecutive Director
  • Pankaj GuptaExecutive Director
  • Ravi PrakashDeputy Company Secretary
Poly Medicure Share Price FAQs

Poly Medicure is trading at 1694.00 as on Tue May 12 2026 09:59:58. This is 2.69% upper as compared to its previous closing price of 1649.70.

The market capitalization of Poly Medicure is 17111.70 Cr as on Tue May 12 2026 09:59:58.

The average broker rating on Poly Medicure is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Poly Medicure is 2587.55 whereas the 52 wk low is 1184.00

Poly Medicure can be analyzed on the following key metrics -

  • TTM P/E: 51.94
  • Sector P/E: -
  • Dividend Yield: 0.21%
  • D/E ratio: -

Poly Medicure reported a net profit of 338.56 Cr in 2025.

The Mutual Fund Shareholding was 8.84% at the end of 31 Mar 2026.